The NuvaRing Master Settlement Agreement drawn up in February 2014 for the NuvaRing multidistrict litigation (MDL) being heard in Missouri has been accepted by both parties, and is moving forward with funding fulfillment. The manufacturer of the NuvaRing, Organon, offered a $100 million settlement, and according to a recent court order, the deadline for complete funding is August 13, 2014.
As stated in the NuvaRing Master Settlement Agreement, claims that have not yet been filed may qualify for participation in the settlement if the case involves an injury associated with the use of the NuvaRing, and if the injury occurred before February 7, 2014.
The defective medical device lawyers at Carey Danis & Lowe are pleased to see that the NuvaRing settlement is progressing in a smooth fashion, especially in light of the severe injuries sustained by the plaintiffs involved in the litigation. As a personal injury law firm that represents NuvaRing victims, Carey Danis & Lowe hopes that all qualified plaintiffs receive their compensation packages in a swift manner so that they may move on from any matters involving the NuvaRing.
If you or someone you love has been injured by a defective medical device, explore your legal options and compensation eligibility with Carey Danis & Lowe. Our team of experienced trial lawyers have been extremely successful in winning cases, and have recovered over $1 billion on behalf of our clients.
Share your NuvaRing story with Carey Danis & Lowe today. Our attorneys are available to evaluate your case in a free initial consultation. Contact Carey Danis & Lowe by phone at 800.721.2519, or complete a personal injury claim form.References: NuvaRing, Pharmaceutical litigation